| News






Search website:

Website Members



Secure login:

Username:

Password:



Gold Partners:

Below is a list of archived news items.  Please select a news date and title to view details...


2/1/2008
Deloitte - Lead Advisor to BioMS on the largest Biotech Alliance

1/22/2008
Alberta Apprenticeship and Industry Training Board Appoints New Member

1/8/2008
Ceapro Announces Granting of Stock Options


1/7/2008
Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment

12/18/2007
Lilly and BioMS Medical Announce Global Licensing and Development Agreement

12/17/2007
Oncothyreon to Receive $5 Million Payment


12/17/2007
University Technologies International & BioAlberta Create Partnership to Strengthen Calgary’s Bioindustry

12/7/2007
Innovotech Files with the US Environmental Protection Agency (EPA) for Novel Seed Treatment Product

12/5/2007
QSV Biologics Ltd. Awarded Company of theYear

12/3/2007
CardioMetabolics™ Recognized as Emerging Company of the Year

11/28/2007
2007 Alberta Bioindustry Award Winners Announced

11/16/2007
Natraceutical Group Acquires Viscofiber® from Cevena Bioproducts Inc.

11/14/2007
Cyplasin Biomedical Ltd. Announces Second U.S. Patent for Cyplasin

11/14/2007
Picomole Instruments Builds LifeSens Prototype


10/22/2007
Stem Cell Therapeutics Corp. Enters Into a Bought Deal Agreement for Gross Proceeds of $10.5 Million


10/4/2007
QSV Biologics Recruits Project Manager From Pfizer Inc.


10/1/2007
Ceapro: Issuance of Stock Options


10/1/2007
Biomira Announces Plan to Change Name to Oncothyreon


10/1/2007
AHFMR and BioAlberta Establish Partnership to Boost expertise in Early Stage biotechnology Companies

9/21/2007
Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent

9/21/2007
Resverlogix's HDL Preclinical Data is Published in Current Opinion in Investigational Drugs


9/21/2007
PBR Laboratories Inc. Granted Establishment Licence for GMP testing by Health Canada

9/21/2007
Biomira Announces Plan to Reincorporate in the United States

9/17/2007
Stella M. Thompson Joins Resverlogix Board of Directors

9/10/2007
Call for Nominations - BioAlberta Achievement Awards

9/7/2007
Cyplasin-SC TM Kills Melanoma Cells, Even Derived From Different Patients but Leaves Normal Human Cells Unharmed

8/2/2007
FDA Allows Long Term Use Of Isa247 In Isotechnika Phase 2b Kidney Transplant Trial

8/1/2007
Provincial Program to Boost Bio-Energy Production in Alberta

8/1/2007
Ceapro Diabetes Screening Patent Granted

7/24/2007
Stem Cell Therapeutics Corp. Announces Initiation of Preclinical Comparator TBI Study

7/24/2007
Resverlogix Announces a Second Proof-of-Concept Milestone

7/16/2007
Recipe for Low-Cost Medical Tests: FISH and Chips

7/12/2007
SemBioSys Achieves Critical Apo AI Milestone

7/12/2007
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position


7/11/2007
QSV Biologics Ltd. and Alseres Pharmaceuticals Inc. Sign Contract for cGMP Manufacture of Cethrin® for Spinal Cord Injury

7/9/2007
3M Canada Company Forms Alliance With Cantega™ Technologies Inc. 

6/19/2007
Stem Cell Therapeutics Corp. to Present at the BIO VentureForum East 2007


6/18/2007
Resverlogix Collaborates NexVas(TM) AD Program with Leading Alzheimer's Researcher at Sun Health Research Institute

6/18/2007
The CFI Awards $810,975 to the University of Alberta in Support of Five Researchers

6/12/2007
Resverlogix Closes US $25M Financing

6/12/2007
CardioMetabolics Secures $4M Financing


6/7/2007
Health Canada Allows Isotechnika To Continue Patients On Isa247 Until Commercialization

6/5/2007
BioMS Medical Initiates Enrollment in Pivotal U.S. Phase III Multiple Sclerosis Trial

5/31/2007
ViRexx Announces Collaboration With the National Institute of Nanotechnology (NINT) and Defence Research and Development Canada Suffield (DRDC Suffield) With Networking and Financial Contribution


5/28/2007
ToxTest Announces Appointment of Dr. Hugh Semple

5/18/2007
Ceapro Building Momentum: Reports Steady Growth in Q1 Sales and Operational Profitability

5/15/2007
BioMS Medical to Raise $38,500,000


5/14/2007
Biotechnology Entrepreneurial Spirit Sweeps VenturePrize

5/14/2007
BioMS Medical To Present At Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference

5/11/2007
Isotechnika's Lead Drug, Isa247, To Be Highlighted At The Association For Research In Vision And Ophthalmology (Arvo) Annual Meeting

5/4/2007
Alberta Atrracts International Biodiesel Investment

5/2/2007
Westlink Innovation Applications being Accepted for the Technology Commercialization Internship Program

4/28/2007
BioAlberta Profiles Student Biotechnology Projects - Sanofi Aventis Biotech Challenge

4/23/2007
Isotechnika To Update Investment Community At Biofinance Business Forum

4/20/2007
Stem Cell Therapeutics Corp. Announces Presentations at EQUITIES Magazine 56th Anniversary Spring Conference & BioFinance


4/20/2007
BioMS Medical Announces Lead Investigator in United States Phase III Multiple Sclerosis Trial

4/11/2007
Stem Cell Therapeutics Corp. Announces Positive Interim Results from its Currently Enrolling Phase IIa Clinical Program for NTx™-265 in Acute Stroke

4/11/2007
COLD-fX(R) is Canada's #1 Pharmacist Recommended Natural Cold Remedy for the Second Straight Year

4/11/2007
BP BioFuels Bets on Butanol

4/11/2007
Oncolytics Biotech Inc. Proceeds to Initiate U.S. Phase II Sarcoma Clinical Trial

4/10/2007
Isotechnika To Host Educational Symposium At The American Transplant Congress

3/28/2007
AHFMR Gives TEC Edmonton Funding to Help Tech Ventures

3/27/2007
Isotechnika’s Independent Data Monitoring Committee Conducts Review Of Phase 2b Kidney Transplant Trial

3/20/2007
Alberta Business Plan Competition Showdown set for May 3 at Shaw Conference Centre


3/15/2007
Biomira to Present at Two Upcoming Investor Conferences

3/15/2007
Ceapro to Present at Investor Conference

3/15/2007
Oncolytics Biotech Inc. to Present at Invest Northwest CEO and Investor Conference

3/6/2007
Oncolytics Biotech Inc. Announces Issuance of 19th U.S. Patent

2/28/2007
DOE Selects Six Cellulosic Ethanol Plants for Up to $385 Million in Federal Funding Funding to help bring cellulosic ethanol to market and help revolutionize the Industry


2/6/2007
Alberta Biotech Company, Sage Biosciences teams up with ARC for New Product Development

1/29/2007
QSV Biologics, Ltd. Signs cGMP Manufacturing Contract for a Therapeutic Recombinant Protein with a US Biopharmaceutical Company

1/19/2007
BioMS Medical Cleared by FDA to initiate pivotal phase III Multiple Sclerosis Trial

1/16/2007
Oncolytics Biotech Inc. Announces Issuance of 18th U.S. Patent

1/3/2007
BioAlberta and TEC Edmonton forge alliance, EEDC boss presented Enterprise Award

12/4/2006
Northern Alberta Clinical Trials And Research Centre (Nactrc) To Be Western Canada’s Clinical Research Leader By 2010

 

 

 

 

 

 

 






 
 Member login / secure access
 Apply for membership
 View all members

 Ceapro Licenses New Mint Variety: Will Develop Extracts for Innovative Cosmeceuticals and Nutraceuticals

 Stem Cell Therapeutics Corp. Congratulates Dr. Samuel Weiss on His Receipt of the Gairdner Award

 Picomole Demonstrates the Power of LifeSensTM technology to measure biomarkers in exhaled breath Samples

 Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial

 Oncothyreon Announces Effectiveness of Shelf Registration Statement


 View all news
 View news archives

 << May 2008 >> 
S M T W T F S
       
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31


View all events